NCT00482963 A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication Status COMPLETED Phase PHASE1
NCT00482703 A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00481325 Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder Status COMPLETED Phase PHASE2/PHASE3
NCT00481247 A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Status COMPLETED Phase PHASE3
NCT00479583 Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX Status COMPLETED Phase PHASE1
NCT00468169 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00461110 A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) Status TERMINATED Phase PHASE1
NCT00460954 A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects Status COMPLETED Phase N/A
NCT00457002 Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness Status COMPLETED Phase PHASE3
NCT00455533 Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer Status COMPLETED Phase PHASE2
NCT00455013 A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation Status COMPLETED Phase PHASE2
NCT00452673 Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00452530 Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery Status COMPLETED Phase PHASE3
NCT00448097 Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy Status TERMINATED Phase PHASE2